Axsome Therapeutics (AXSM) had the best year in 2019 by a US stock with a market cap of $2B+ in 2019, returning 3,578.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | 2019 | 3,578.29% |
Enphase Energy (ENPH) | 2019 | 464.36% |
Arrowhead Pharmaceuticals (ARWR) | 2019 | 421.63% |
Roku (ROKU) | 2019 | 349.03% |
Sea (SE) | 2019 | 261.69% |
Sibanye Gold Ltd ADR (SBSW) | 2019 | 243.6% |
Immunitybio (IBRX) | 2019 | 238.39% |
Iovance Biotherapeutics (IOVA) | 2019 | 215.62% |
Intracellular Th (ITCI) | 2019 | 208.54% |
Snap (SNAP) | 2019 | 203.53% |
Shopify (SHOP) | 2019 | 196.7% |
Carvana (CVNA) | 2019 | 190.56% |
Eldorado Gold (EGO) | 2019 | 179.79% |
Lattice Semiconductor (LSCC) | 2019 | 179.01% |
TG Therapeutics (TGTX) | 2019 | 174.75% |
Palomar (PLMR) | 2019 | 172.92% |
Boot Barn (BOOT) | 2019 | 172.52% |
Krystal Biotech (KRYS) | 2019 | 171.2% |
ACADIA Pharmaceuticals (ACAD) | 2019 | 170.08% |
Vipshop (VIPS) | 2019 | 166.35% |
Advanced Micro Devices (AMD) | 2019 | 154.64% |
Cirrus Logic (CRUS) | 2019 | 153.18% |
Natera (NTRA) | 2019 | 146.81% |
Builders FirstSource (BLDR) | 2019 | 138.37% |
Frontline (FRO) | 2019 | 137.6% |
